CLSDQ- Clearside Biomedical, Inc.
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 11 buys and 2 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Thorp Clay62 | Director | Buy | 15,000 | $0.92 | $13,800.00 | +9.3% | -6.9% | - | |
| Nov 1, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Buy | 36,500 | $1.00 | $36,500.00 | +57.5% | -6.4% | -73.1% | |
| Jun 24, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Buy | 23,500 | $1.06 | $24,910.00 | +58.8% | +11.1% | -23.1% | |
| May 15, 2024 | Yerxa Benjamin R | Director | Buy | 7,813 | $1.31 | $10,235.03 | +77.0% | -19.3% | -34.5% | |
| Apr 18, 2024 | Gibney Anthony S | Director | Buy | 100,000 | $1.30 | $129,664.50 | +1,490% | -8.3% | -34.8% | |
| Mar 20, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Buy | 30,000 | $1.60 | $48,000.00 | New | -31.3% | -38.0% | |
| Feb 7, 2024 | Whitmore Bradford T76 | 10% Owner | Buy | 444,444 | $1.35 | $599,999.40 | +11.0% | -7.2% | -22.5% | |
| Jan 19, 2024 | Lasezkay George M71 | CEO | Sell | 18,000 | $1.27 | $22,860.00 | -3.7% | +2.3% | -27.9% | |
| Jan 19, 2024 | Deignan Charles A.69 | Chief Financial Officer | Sell | 12,900 | $1.28 | $16,512.00 | -3.2% | +2.3% | -27.9% | |
| Nov 1, 2023 | Whitmore Bradford T76 | 10% Owner | Buy | 135,778 | $0.74 | $99,849.15 | +1.1% | +75.6% | +33.7% |
Page 1Next →